Duality Advisers, LP Edwards Lifesciences Corp Transaction History

Duality Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$69.28 - $93.38 $4.07 Million - $5.49 Million	58,790 New	58,790 $4.07 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $4.76 Million - $6.2 Million	57,817 New	57,817 $4.78 Million
Q4 2021 Feb 02, 2022	SELL	$106.37 - $130.68 $3.93 Million - $4.83 Million	-36,939 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$102.91 - $122.75 $3.8 Million - $4.53 Million	36,939 New	36,939 $4.18 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $1.67 Million - $1.93 Million	-21,251 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$71.69 - $91.23 $6.76 Million - $8.6 Million	-94,319 Reduced 81.61%	21,251 $1.94 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $3.95 Million - $5.14 Million	58,791 Added 103.54%	115,570 $9.23 Million
Q2 2020 Jul 29, 2020	BUY	$57.54 - $76.95 $3.27 Million - $4.37 Million	56,779 New	56,779 $3.92 Million
Q3 2019 Nov 08, 2019	SELL	$61.55 - $75.43 $108,943 - $133,511	-1,770 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $98,659 - $114,005	1,770 New	1,770 $327,000
Q1 2019 May 13, 2019	SELL	$47.89 - $64.05 $272,494 - $364,444	-5,690 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$46.41 - $56.94 $264,072 - $323,988	5,690 New	5,690 $872,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.